| Income Statement |
| Total Revenue | 1.17B |
|
| Revenues (USD) | 1.17B |
| Cost of Revenue | 576.90M |
| Gross Profit | 589.06M |
| Operating Expenses | 441.80M |
| Research and Development Expense | 202.55M |
| Selling, General and Administrative Expense | 239.25M |
| Operating Income | 147.26M |
| Income Tax Expense | -1.45B |
| Net Income | 1.62B |
| Net Income Common Stock | 1.62B |
| Net Income Common Stock (USD) | 1.62B |
| Consolidated Income | 1.62B |
| Earnings per Basic Share | 4.82 |
| Earnings per Basic Share (USD) | 4.82 |
| Earnings per Diluted Share | 4.63 |
| Earning Before Interest & Taxes (EBIT) | 169.09M |
| Earning Before Interest & Taxes (USD) | 169.09M |
| Weighted Average Shares | 339.04M |
| Weighted Average Shares Diluted | 349.72M |
| Balance Sheet |
| Cash and Equivalents | 2.43B |
| Cash and Equivalents (USD) | 2.43B |
| Investments | 10.01B |
| Trade and Non-Trade Receivables | 284.35M |
| Property, Plant & Equipment Net | 685.83M |
| Total Assets | 15.79B |
| Total Debt | 9.99B |
| Total Liabilities | 10.31B |
| Accumulated Retained Earnings (Deficit) | -1.13B |
| Accumulated Other Comprehensive Income | -36.37M |
| Shareholders Equity | 5.48B |
| Shareholders Equity (USD) | 5.48B |
| Total Debt (USD) | 9.99B |
| Goodwill and Intangible Assets | 550.87M |
| Trade and Non-Trade Payables | 84.65M |
| Tax Assets | 1.47B |
| Cash Flow |
| Depreciation, Amortization & Accretion | 87.35M |
| Net Cash Flow from Financing | 865.65M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -41.26M |
| Capital Expenditure | -66.87M |
| Issuance (Purchase) of Equity Shares | 16.25M |
| Issuance (Repayment) of Debt Securities | 923.41M |
| Net Cash Flow from Investing | -1.20B |
| Net Cash Flow - Investment Acquisitions and Disposals | -1.13B |
| Net Cash Flow from Operations | 296.16M |
| Effect of Exchange Rate Changes on Cash | -4.81M |
| Share Based Compensation | 67.18M |